- Home
- BLRX vs NCPL Comparison
BLRX vs NCPL Comparison
Compare BLRX & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- NCPL
- Stock Information
- Founded
- BLRX 2003
- NCPL 1984
- Country
- BLRX Israel
- NCPL United States
- Employees
- BLRX N/A
- NCPL N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- NCPL Investment Managers
- Sector
- BLRX Health Care
- NCPL Finance
- Exchange
- BLRX Nasdaq
- NCPL Nasdaq
- Market Cap
- BLRX 17.0M
- NCPL 16.1M
- IPO Year
- BLRX 2011
- NCPL N/A
- Fundamental
- Price
- BLRX $3.71
- NCPL $1.99
- Analyst Decision
- BLRX Strong Buy
- NCPL
- Analyst Count
- BLRX 2
- NCPL 0
- Target Price
- BLRX $19.00
- NCPL N/A
- AVG Volume (30 Days)
- BLRX 40.4K
- NCPL 239.8K
- Earning Date
- BLRX 08-14-2025
- NCPL 08-12-2025
- Dividend Yield
- BLRX N/A
- NCPL N/A
- EPS Growth
- BLRX N/A
- NCPL N/A
- EPS
- BLRX N/A
- NCPL N/A
- Revenue
- BLRX $17,251,000.00
- NCPL $869,460.00
- Revenue This Year
- BLRX N/A
- NCPL N/A
- Revenue Next Year
- BLRX N/A
- NCPL $101.16
- P/E Ratio
- BLRX N/A
- NCPL N/A
- Revenue Growth
- BLRX 1.19
- NCPL N/A
- 52 Week Low
- BLRX $2.30
- NCPL $1.41
- 52 Week High
- BLRX $32.26
- NCPL $8.75
- Technical
- Relative Strength Index (RSI)
- BLRX 39.17
- NCPL 32.73
- Support Level
- BLRX $3.58
- NCPL $1.86
- Resistance Level
- BLRX $4.17
- NCPL $3.18
- Average True Range (ATR)
- BLRX 0.27
- NCPL 0.36
- MACD
- BLRX -0.01
- NCPL -0.10
- Stochastic Oscillator
- BLRX 37.11
- NCPL 7.40
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.